Naomi Kuramoto - Department for the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 7 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data

Yasutoshi Sakamoto,Hideaki Bando,Yoshiaki Nakamura,Hiromi Hasegawa,Takako Kuwaki,Wataru Okamoto,Hiroya Taniguchi, Yoshihiro Aoyagi,Izumi Miki,Hiroshi Uchigata,Naomi Kuramoto,Nozomu Fuse,Takayuki Yoshino,Atsushi Ohtsu

Clinical colorectal cancerno. 1 (2023): 45-52

Cited4Views0WOSBibtex

O4-3 Utility of an artificial intelligence-curation system, QA Commons, for clinical sequencing: SCRUM-Japan MONSTAR-SCREEN

Satoshi Horasawa,Takao Fujisawa,Yasutoshi Sakamoto,Naomi Kuramoto,Yoshiaki Nakamura,Hiroya Taniguchi,Takayuki Yoshino

ANNALS OF ONCOLOGY（2021）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn